DUBENSKY Thomas W. Jr.,HOSKEN Nancy A.,ROBBINS Scott H.,MOORE Margaret D.
申请号：
SI201331065
公开号：
SI2850431T1
申请日:
2013.05.16
申请国别(地区):
SI
年份:
2018
代理人:
摘要：
Compositions of recombinant HSV-2 proteins and an agonist of the innate immune system, such as an adjuvant, are provided as a vaccine. Proteins include an envelope glycoprotein and a structural protein other than an envelope glycoprotein, e.g., a capsid or tegument protein. The vaccine is for use in either HSV-2 seropositive or seronegative subjects.
